Related Experiment Videos

De novo membranous glomerulonephritis in renal allografts in children

C Antignac1, N Hinglais, M C Gubler

  • 1INSERM U. 192, Necker Hospital, Paris, France.

Clinical Nephrology
|July 1, 1988
PubMed

Insights

De novo membranous glomerulonephritis (MGN) was found in 9.3% of kidney transplants, a higher incidence than previously reported. Many cases presented without proteinuria, highlighting the need for careful monitoring post-transplant.

Area of Science:

  • Nephrology
  • Transplant Immunology
  • Pathology

Background:

  • De novo membranous glomerulonephritis (MGN) is a rare complication of kidney transplantation, typically occurring in 1-2% of cases.
  • Subepithelial IgG deposits are the hallmark of MGN, indicating an immune-mediated glomerular injury.

Purpose of the Study:

  • To investigate the incidence and characteristics of de novo membranous glomerulonephritis in kidney transplant recipients.
  • To evaluate the diagnostic methods and clinical presentation of MGN in the context of kidney transplantation.

Main Methods:

  • Immunofluorescence microscopy (IF) was used to examine 310 kidney grafts for subepithelial IgG deposits.
  • Electron microscopy (EM) confirmed the diagnosis in a subset of cases.
  • Clinical data, including proteinuria, renal function, and follow-up, were analyzed.

Main Results:

  • Of 310 grafts, 29 (9.3%) showed IgG deposits consistent with MGN.
  • Biopsies were performed due to proteinuria (8 pts), suspected rejection (16 pts), or systematically (9 pts).
  • Proteinuria developed in 23 patients post-transplant, with 6 experiencing nephrotic syndrome.

Conclusions:

  • The incidence of de novo MGN in kidney transplants may be higher than previously estimated.
  • MGN can present without proteinuria, emphasizing the importance of systematic graft evaluation.
  • Persistence or increase of IgG deposits suggests ongoing disease activity.

Related Concept Videos